Viewing Study NCT00330460


Ignite Creation Date: 2025-12-25 @ 2:01 AM
Ignite Modification Date: 2026-06-04 @ 6:29 PM
Study NCT ID: NCT00330460
Status: COMPLETED
Last Update Posted: 2011-01-24
First Post: 2006-04-06
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Randomized, Double-Blind Study to Compare the Efficacy of Treatment With Denosumab Versus Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density.
Sponsor: Amgen
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Osteoporosis View
None Osteopenia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Osteoporosis View
None Osteopenia View
None AMG 162 View
None Fracture - hip View
None Postmenopausal View